Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
4.915
+0.025 (0.51%)
At close: Aug 13, 2025, 4:00 PM
4.910
-0.005 (-0.10%)
After-hours: Aug 13, 2025, 4:20 PM EDT
Organogenesis Holdings Employees
Organogenesis Holdings had 869 employees as of December 31, 2024. The number of employees increased by 7 or 0.81% compared to the previous year.
Employees
869
Change (1Y)
7
Growth (1Y)
0.81%
Revenue / Employee
$494,282
Profits / Employee
-$17,937
Market Cap
623.51M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ORGO News
- 5 days ago - Organogenesis Holdings Inc. (ORGO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Organogenesis Holdings Inc. Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 22 days ago - Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025 - GlobeNewsWire
- 4 weeks ago - Organogenesis Applauds CMS Proposal to Reform Skin Substitute Payment Policy; Urges Refinements to Ensure Patient Access to Appropriate Products and Continued Innovation - GlobeNewsWire
- 2 months ago - Organogenesis Holdings: ReNu And New LCD Offer A Rebound Scenario - Seeking Alpha
- 3 months ago - Organogenesis Holdings Inc. (ORGO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Organogenesis Holdings Inc. Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 4 months ago - Organogenesis Supports CMS' Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness - GlobeNewsWire